Market Overview

CDCP Warns Prescription Drug Abuse Deaths Are on the Rise

Share:

The Centers for Disease Control and Prevention said that drug overdoseis now one of the leading causes of accidental death in the United States, accounting to an estimated 100 deaths per day in America. Majority of the deaths are directly related to prescription drugs, the CDCP said.

“Prescription drugabuse is the fastest growing drug problem in the United States,” the CDCP said. These prescription drugs include the so-called opioid analgesics that suppress the person’s perception of pain, and psychiatric drugs which are available in various forms such as antipsychotics, antidepressants, hallucinogens, mood stabilizers, stimulants, anti-anxiety drugs and hypnotics. 

And in many instances, these prescription drugs, which are being used by approximately 50 million Americans, can be obtained without a prescription from a doctor. In fact in the last decade, there were more deaths involving the overdose of opioid analgesics than heroin and cocaine combined, the CDCP said.  In a separate study by the Trust for America’s Health, a nonprofit organization that studies U.S. health policies, about 6.1 million people abuse prescription pills.

Due to the serious threat of prescription drug abuse, the medical sector is finding ways to control what they called an “epidemic.”  “We’ve been struck how quickly this probably has emerged … it warrants a strong public health response,” says Andrea Gielen, director of the Johns Hopkins Center for Injury Research and Policy in Baltimore, who served as a consultant for the Trust for America’s Health report. “We’re concerned about preventing misuse or overdoses, which are very real and heart-wrenching problems that have been skyrocketing recently.”

In response to this growing medical problem, one major doctors’ organization has called upon its members to practice greater caution and restraint when prescribing such medications.  The American College of Physicians has recommended both procedural and clinical changes to discourage abusers of common prescription drugs.  The organization has expressed the need for public education on the dangers and consequences of both medical and non-medical use of prescription drugs.

The ACP also supports the Prescription Drug Monitoring Program (PDMP) where medical providers can check before they write prescriptions for substances which have high potential for abuse. 

“In general, the medical community has been very liberal with their prescribing of opioids to treat pain in recent times. While this has not been the only cause of the problem, it has been a significant contributor,” said Brady Granier, COO of BioCorRx Inc.

But more than these moves, medical schools should address the need to provide proper education to medical students in the field of addiction. “There is a fundamental lack of education about addiction medicine and treating patients with substance use disorder provided in medical school, as well as internships and residency programs,” according to  Janina Kean, substance abuse and addiction expert.

Studies show that the most common misused prescription drugs are painkillers, depressants and stimulants.  Men ages 25 to 54 are most likely to abuse these drugs but the number of women abusers are increasing. According to the Trust for America’s Health report, every state has a monitoring program for prescription drugs but the strategies are often broad, or fail due to funding and capability.

Another monitoring problem is that some state providers do not have access to Prescription Drug Monitoring Programs, according to Jeffrey Levy, executive director of Trust for America’s Health.  PDMP are electronic databases used to track prescriptions by patients and can serve as an alarm in case of  misuse as it can track multiple prescriptions by different doctors.

One healthcare solutions development company has developed a highly effective addiction treatment program called the Start Fresh Program that is used by various independently owned licensed addiction clinics throughout the country to treat alcoholism and select opioid addictions.

Developed by BioCorRx, Inc. (OTCQB: BICX), The Start Fresh Program (SFP) consists of two components; one is the administration of the highly effective, propriety implant compound of the FDA-approved drug naltrexone, which significantly reduces cravings for alcohol and opiates, and a life-coaching program that is tailored specifically to substance abuse addicts. The implant is administered as an outpatient procedure, thus in most cases, patients do not need to miss more than one day of work. Thereafter, the life-coaching program can be privately done in a one on one setting.

BioCorRx’s revolutionary Start Fresh Program has a very high success rate as reported by patients in routine telephone and face-to-face interviews conducted by the independently owned and operated clinics using the SFP.

The company’s Start Fresh Program also incorporates a private, one-on-one life coaching program for alcoholics to help them plan for a life without substance abuse.

Interested parties can learn more about BioCorRx Inc.’s Start Fresh Program by contacting its corporate office at 714-462-4880714-462-4880 or by visiting www.startfreshprogram.com.

 

 

 
 

The following article is from one of our external contributors. It does not represent the opinion of Benzinga and has not been edited.

 

Related Articles

View Comments and Join the Discussion!